Dementia and Alzheimer Disease

The NeurologyLive dementia and Alzheimer disease clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to the care of patients with dementia and similar diseases, including Lewy body dementia, frontotemporal dementia, Alzheimer disease, and more.

Episode 24: Aducanumab and Alzheimer Disease Clinical Trials

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive look into the discussion surrounding aducanumab and how it reflects the challenges of conducting clinical trials in Alzheimer disease.

Support, Skepticism, and Statistics: The Aducanumab Saga

After a sudden reversal and complex analyses, aducanumab’s future rests in the hands of the FDA while the community stands split on if the available data are enough to justify an approval.

Compounding Challenges: Conducting Clinical Trials in Alzheimer Disease

Treating Alzheimer disease presents a spiderweb of complexity for physicians, and its intricacies have made assessing therapies equally puzzling.

NeurologyLive Friday 5 — July 23, 2021

July 23, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 23, 2021.

Biogen Head Pens Open Letter Regarding Aducanumab Controversy in Alzheimer

July 23, 2021

Article

Alfred Sandrock, MD, PhD, head of research and development, Biogen, has published an open letter to the Alzheimer community in an attempt to clarify “misinformation and misunderstanding” that has moved “outside the boundaries of legitimate scientific deliberation.”

Social Determinants of Health in Alzheimer Disease: Jessica Zwerling, MD

July 23, 2021

Video

The associate director of the Center for the Aging Brain at Montefiore Medical Center commented on social determinants of health in relation to telemedicine and community willingness to engage.

AI-Computerized Cognitive Assessment Aids in Diagnosing MCI and Mild AD

July 23, 2021

Article

The Integrated Cognitive Assessment showed convergent validity with both MoCA and ACE and offers potential for remote measurement of cognitive performance in Alzheimer disease and mild cognitive impairment.

TRAIN-AD Intervention Strategies Fail to Reduce Antimicrobial Use in AD Patients

July 20, 2021

Article

The study data suggest that intervention strategies to improve antimicrobial and burdensome intervention for suspected LRIs and UTIs are ineffective.

Implementing and Maintaining Telehealth for Alzheimer Disease: Jessica Zwerling, MD

July 19, 2021

Video

Challenges surrounding the use of telehealth for patients with Alzheimer disease are affected by technological barriers, according to the associate director of the Center for the Aging Brain at Montefiore Medical Center.

Telehealth for Patients with Alzheimer Disease: Jessica Zwerling, MD

July 19, 2021

Video

The associate director of the Center for the Aging Brain at Montefiore Medical Center discusses the use of telehealth for patients with Alzheimer disease during the COVID-19 pandemic, as well as her thoughts on why it is here to stay.

This Week on NeurologyLive — July 19, 2021

July 19, 2021

Article

Here's what is coming soon to NeurologyLive.

Is Telemedicine Here to Stay for Alzheimer and Dementia Care?

July 18, 2021

Article

Jessica Zwerling, MD, associate director, Center for the Aging Brain, Montefiore Medical Center, discussed the impact that telemedicine has had in Alzheimer and dementia care.

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

July 17, 2021

Video

Neurology News Network for the week ending July 17, 2021.